Hims & Hers Health Inc (HIMS)

$55.50 +3.74 (7.23%)
Market Cap 12.54B
Revenue (ttm) 1.48B
Net Income (ttm) 126.04M
EPS (ttm) N/A
PE Ratio 95.85
Forward PE 86.54
Profit Margin 8.54%
Debt to Equity Ratio 0.00
Volume 35,502,200
Avg Vol 30,397,270
Day's Range N/A - N/A
Shares Out 226.02M
Stochastic %K 97%
Beta 2.14
Analysts Sell
Price Target $48.67

Company Profile

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-cou...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 415 851 0195
Address:
2269 Chestnut Street, Suite 523, San Francisco, United States
Marketwatcher71
Marketwatcher71 Sep. 14 at 9:47 AM
$HIMS so the FDA will hunt them down and bankrupt them?
0 · Reply
PreciseSVJ
PreciseSVJ Sep. 14 at 2:14 AM
$HIMS Yeah now they are entering the crosshairs of the FDA. Get out
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 11:47 PM
Enter: $HIMS OCT 10 2025 $56 CALLS Buy in Price: $4.80 - $4.85 Take Profit: $6.14 Stop Bleeding: $4.22 ROI Potential: 28% Exit Within: 76 Minutes https://moneygroup.us/alerts
0 · Reply
mcm5611
mcm5611 Sep. 13 at 8:37 PM
$HIMS Entry level stock basher wannabe🤣🤣🤣
1 · Reply
mcm5611
mcm5611 Sep. 13 at 8:36 PM
$HIMS Even a blind squirrel can find a nut🤷‍♂️
1 · Reply
mcm5611
mcm5611 Sep. 13 at 8:36 PM
$HIMS $NVO Useless bot post Please delete this account
0 · Reply
satsandstocks
satsandstocks Sep. 13 at 6:20 PM
$HIMS break 38 goes to 23 - break 73 - then blue sky (86, 103) = everything else in between is a consolidation
0 · Reply
WallstreetPatron43
WallstreetPatron43 Sep. 13 at 5:33 PM
$HIMS 65-70$ upcoming week
0 · Reply
Omegacy2
Omegacy2 Sep. 13 at 4:17 PM
$HIMS closed 55.5s as i pt 50-55+. i was in 51.7s and out 53. i was in 42 and out 50-55 before that. i called 28.5s it bounce 50s 2 previous er.
0 · Reply
KirRoyalTrader
KirRoyalTrader Sep. 13 at 2:57 PM
$HIMS - Daily Looks like we are going for another ride with Hims & Hers ... 🎢
1 · Reply
Latest News on HIMS
US FDA chief says Super Bowl ad by Hims & Hers 'breached' drug promotion rules

Sep 12, 2025, 6:52 PM EDT - 1 day ago

US FDA chief says Super Bowl ad by Hims & Hers 'breached' drug promotion rules

Hims & Hers Looks Like Hyper Growth At A Reasonable Price

Sep 10, 2025, 10:52 PM EDT - 3 days ago

Hims & Hers Looks Like Hyper Growth At A Reasonable Price

Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform

Sep 10, 2025, 11:30 AM EDT - 3 days ago

Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform

Hims & Hers Bets On Hormonal Health To Revive Investor Confidence

Sep 10, 2025, 11:13 AM EDT - 3 days ago

Hims & Hers Bets On Hormonal Health To Revive Investor Confidence

Hims & Hers: The Next Chapter For Investors

Sep 10, 2025, 10:15 AM EDT - 3 days ago

Hims & Hers: The Next Chapter For Investors

Hims & Hers launches treatment plans for low testosterone

Sep 10, 2025, 9:39 AM EDT - 3 days ago

Hims & Hers launches treatment plans for low testosterone

Hims Launches New Category in Men's Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

Sep 10, 2025, 9:00 AM EDT - 3 days ago

Hims Launches New Category in Men's Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

Hims & Hers Health Expands Testosterone Offerings

Sep 10, 2025, 8:50 AM EDT - 3 days ago

Hims & Hers Health Expands Testosterone Offerings

Trump aims to curb direct-to-consumer ads for drugs. Hims & Hers Health could be targeted.

Sep 9, 2025, 7:12 PM EDT - 4 days ago

Trump aims to curb direct-to-consumer ads for drugs. Hims & Hers Health could be targeted.

Hims & Hers Health: At The Intersection Of Secular Megatrends

Sep 5, 2025, 5:58 PM EDT - 8 days ago

Hims & Hers Health: At The Intersection Of Secular Megatrends

Hims & Hers Health: Still Undervalued

Aug 31, 2025, 3:24 AM EDT - 14 days ago

Hims & Hers Health: Still Undervalued

Hims & Hers: The Dominant Health Platform Of The Future

Aug 29, 2025, 6:26 PM EDT - 15 days ago

Hims & Hers: The Dominant Health Platform Of The Future

Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire

Aug 25, 2025, 2:26 PM EDT - 19 days ago

Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire

OSCR RKT

Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS

Aug 25, 2025, 3:08 AM EDT - 20 days ago

Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS

Hims & Hers (HIMS) Stock Lawsuits: Investors Urged to Act - Hagens Berman

Aug 24, 2025, 10:26 AM EDT - 20 days ago

Hims & Hers (HIMS) Stock Lawsuits: Investors Urged to Act - Hagens Berman

Hims & Hers: Personalized Care To Sustain Revenue Growth Despite GLP-1 Hiccup

Aug 22, 2025, 11:51 AM EDT - 22 days ago

Hims & Hers: Personalized Care To Sustain Revenue Growth Despite GLP-1 Hiccup

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

Aug 22, 2025, 10:35 AM EDT - 22 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

Here's How I Am Buying Hims & Hers At $37 Or Earning 4.2% Monthly Instead

Aug 20, 2025, 4:49 AM EDT - 25 days ago

Here's How I Am Buying Hims & Hers At $37 Or Earning 4.2% Monthly Instead

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit – HIMS

Aug 18, 2025, 4:01 PM EDT - 26 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit – HIMS

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims

Aug 18, 2025, 1:11 PM EDT - 26 days ago

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims

GDRX NVO

HIMS' Transformation Into A Precision Health Platform

Aug 15, 2025, 9:32 PM EDT - 4 weeks ago

HIMS' Transformation Into A Precision Health Platform

US FTC investigating Hims & Hers over advertisements and cancellation practices, Bloomberg News reports

Aug 14, 2025, 4:41 PM EDT - 4 weeks ago

US FTC investigating Hims & Hers over advertisements and cancellation practices, Bloomberg News reports

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

Aug 14, 2025, 9:09 AM EDT - 4 weeks ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

Hims & Hers CEO sells $33 million in stock after a massive rally

Aug 12, 2025, 3:21 PM EDT - 4 weeks ago

Hims & Hers CEO sells $33 million in stock after a massive rally

Why is Novo Nordisk excluding Hims & Hers in its lawsuits over Wegovy copies?

Aug 11, 2025, 3:51 PM EDT - 4 weeks ago

Why is Novo Nordisk excluding Hims & Hers in its lawsuits over Wegovy copies?

NVO

As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?

Aug 11, 2025, 6:09 AM EDT - 4 weeks ago

As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?

NVO

Hims & Hers: A High-Risk Bet

Aug 7, 2025, 10:27 AM EDT - 5 weeks ago

Hims & Hers: A High-Risk Bet

Hims & Hers: From Telehealth To Wellness Hub, The Bright Future

Aug 6, 2025, 9:32 PM EDT - 5 weeks ago

Hims & Hers: From Telehealth To Wellness Hub, The Bright Future

Hims & Hers: Still Growing After Breakup With Novo Nordisk

Aug 6, 2025, 1:49 PM EDT - 5 weeks ago

Hims & Hers: Still Growing After Breakup With Novo Nordisk

Hims & Hers: GLP-1 Strategy Is On Dubious Grounds

Aug 6, 2025, 1:00 PM EDT - 5 weeks ago

Hims & Hers: GLP-1 Strategy Is On Dubious Grounds

Wait Out The GLP-1 Storm - Buy The Hims And Hers Post-Earnings Dip

Aug 5, 2025, 1:02 PM EDT - 5 weeks ago

Wait Out The GLP-1 Storm - Buy The Hims And Hers Post-Earnings Dip

Weighing HIMS GLP-1 Trends, NVO Partnership & Other Businesses

Aug 5, 2025, 12:00 PM EDT - 5 weeks ago

Weighing HIMS GLP-1 Trends, NVO Partnership & Other Businesses

NVO

Hims & Hers drops on revenue miss

Aug 5, 2025, 11:23 AM EDT - 5 weeks ago

Hims & Hers drops on revenue miss

Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say

Aug 5, 2025, 11:11 AM EDT - 5 weeks ago

Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say

Hims & Hers falls as declining subscriber base weighs on revenue

Aug 5, 2025, 10:38 AM EDT - 5 weeks ago

Hims & Hers falls as declining subscriber base weighs on revenue

MSFT & META CapEx Good for ORCL, HIMS Sells & PFE Rallies on Earnings

Aug 5, 2025, 10:30 AM EDT - 5 weeks ago

MSFT & META CapEx Good for ORCL, HIMS Sells & PFE Rallies on Earnings

META MSFT ORCL PFE

What's Next For HIMS Stock?

Aug 5, 2025, 9:50 AM EDT - 5 weeks ago

What's Next For HIMS Stock?

Hims & Hers: Buy The Core Engine, Not The Headline

Aug 5, 2025, 8:15 AM EDT - 5 weeks ago

Hims & Hers: Buy The Core Engine, Not The Headline

Hims & Hers: Buy The Earnings Dip, Slowly (Rating Downgrade)

Aug 5, 2025, 7:30 AM EDT - 5 weeks ago

Hims & Hers: Buy The Earnings Dip, Slowly (Rating Downgrade)

Hims & Hers Health, Inc. (HIMS) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 10:05 PM EDT - 5 weeks ago

Hims & Hers Health, Inc. (HIMS) Q2 2025 Earnings Call Transcript

Marketwatcher71
Marketwatcher71 Sep. 14 at 9:47 AM
$HIMS so the FDA will hunt them down and bankrupt them?
0 · Reply
PreciseSVJ
PreciseSVJ Sep. 14 at 2:14 AM
$HIMS Yeah now they are entering the crosshairs of the FDA. Get out
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 11:47 PM
Enter: $HIMS OCT 10 2025 $56 CALLS Buy in Price: $4.80 - $4.85 Take Profit: $6.14 Stop Bleeding: $4.22 ROI Potential: 28% Exit Within: 76 Minutes https://moneygroup.us/alerts
0 · Reply
mcm5611
mcm5611 Sep. 13 at 8:37 PM
$HIMS Entry level stock basher wannabe🤣🤣🤣
1 · Reply
mcm5611
mcm5611 Sep. 13 at 8:36 PM
$HIMS Even a blind squirrel can find a nut🤷‍♂️
1 · Reply
mcm5611
mcm5611 Sep. 13 at 8:36 PM
$HIMS $NVO Useless bot post Please delete this account
0 · Reply
satsandstocks
satsandstocks Sep. 13 at 6:20 PM
$HIMS break 38 goes to 23 - break 73 - then blue sky (86, 103) = everything else in between is a consolidation
0 · Reply
WallstreetPatron43
WallstreetPatron43 Sep. 13 at 5:33 PM
$HIMS 65-70$ upcoming week
0 · Reply
Omegacy2
Omegacy2 Sep. 13 at 4:17 PM
$HIMS closed 55.5s as i pt 50-55+. i was in 51.7s and out 53. i was in 42 and out 50-55 before that. i called 28.5s it bounce 50s 2 previous er.
0 · Reply
KirRoyalTrader
KirRoyalTrader Sep. 13 at 2:57 PM
$HIMS - Daily Looks like we are going for another ride with Hims & Hers ... 🎢
1 · Reply
JohnA111
JohnA111 Sep. 13 at 1:13 PM
$HIMS No resistance on the chart until 65-$70. There will be volatility, just look at the most recent run up. But I think if hold through that volatility, all time high is coming.
0 · Reply
TaoistTrader
TaoistTrader Sep. 13 at 12:25 PM
$HIMS hopefully that cool $1,000,000 that Andrew donated to Trump's inauguration will reduce the likelihood $HIMS gets made an example of when the FDA starts to do it's job again: going from hundreds of FDA cease and desist orders in the 90's to one in 2023 and none in 2024.
0 · Reply
TaoistTrader
TaoistTrader Sep. 13 at 12:16 PM
$HIMS Super Bowl ad comes under fire for violating federal law according to FDA Commissioner Marty Makary …
1 · Reply
LolovanH
LolovanH Sep. 13 at 10:59 AM
$HIMS can someone explain to me the moat of hims? I dont get the valuation
1 · Reply
Dr_Feel_Good
Dr_Feel_Good Sep. 13 at 6:37 AM
Happy Friday Fam!!! Fantastic finish to end the week.. The core running hot into the close $HIMS $TSLA and $SOFI helping the folio finish in the green. Hope Everyone Has A Great Weekend. Some good NFL 🙌🏈 this weekend.. Week 2 LFG!!!!
1 · Reply
trading_signal
trading_signal Sep. 13 at 6:24 AM
$HIMS making new highs on the current run. Looking to hold my runner for 65+
0 · Reply
Markus01
Markus01 Sep. 13 at 4:42 AM
$HIMS Strong week for price action No change to our primary wave count and forecast
0 · Reply
StockDeals
StockDeals Sep. 13 at 4:22 AM
$HIMS $HOOD $NBIS everything triple digit gains
0 · Reply
vishav99
vishav99 Sep. 13 at 4:03 AM
$LULU my speculative take: As Ozempic gains popularity, more people may experience weight loss, which could boost their confidence and desire to update their wardrobes. This could lead to increased spending on stylish, high-quality apparel, potentially benefiting brands like Lululemon, Nike etc. Basically adding brand new customer. $NKE $HIMS $NVO
4 · Reply
EvBullforever13
EvBullforever13 Sep. 13 at 1:43 AM
$OSCR great opportunity… $HIMS Only time…
0 · Reply
Lucy888
Lucy888 Sep. 13 at 1:10 AM
$HIMS which ad in the world included side effects? you bears have very small penis
0 · Reply
ms1307
ms1307 Sep. 13 at 12:29 AM
$HIMS Nice recovery—if current momentum holds, patience could lead to more gains ahead. Overall technicals remain bullish: RSI (~74), MACD and all major moving averages are giving strong buy signals. Resistance now sits in the $55–57 range, then potentially $59–63 toward that $62–70 longer-term outlook. Support is holding around $50–51, with stronger support near $46–48, and a deeper pullback to $44 still within the realm of possibility.
0 · Reply